TY - JOUR
T1 - Inter-modality relationship constrained multi-modality multi-task feature selection for Alzheimer's Disease and mild cognitive impairment identification
AU - Liu, Feng
AU - Wee, Chong Yaw
AU - Chen, Huafu
AU - Shen, Dinggang
N1 - Funding Information:
This work was supported in part by NIH grants EB006733 , EB008374 , EB009634 , AG041721 , MH100217 and AG042599 . This work was also partially supported by the National Research Foundation grant (No. 2012-005741 ) funded by the Korean government. In addition, H. Chen was supported by the 973 project (No. 2012CB517901 ), the Natural Science Foundation of China (Nos. 61125304 and 61035006 ), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20120185110028 ). F. Liu was supported by the China Scholarship Council (No. 2011607033 ) and the Scholarship Award for Excellent Doctoral Student granted by the Ministry of Education (No. A03003023901010 ). Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01AG024904 ). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health ( www.fnih.org ). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles.
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Previous studies have demonstrated that the use of integrated information from multi-modalities could significantly improve diagnosis of Alzheimer's Disease (AD). However, feature selection, which is one of the most important steps in classification, is typically performed separately for each modality, which ignores the potentially strong inter-modality relationship within each subject. Recent emergence of multi-task learning approach makes the joint feature selection from different modalities possible. However, joint feature selection may unfortunately overlook different yet complementary information conveyed by different modalities. We propose a novel multi-task feature selection method to preserve the complementary inter-modality information. Specifically, we treat feature selection from each modality as a separate task and further impose a constraint for preserving the inter-modality relationship, besides separately enforcing the sparseness of the selected features from each modality. After feature selection, a multi-kernel support vector machine (SVM) is further used to integrate the selected features from each modality for classification. Our method is evaluated using the baseline PET and MRI images of subjects obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Our method achieves a good performance, with an accuracy of 94.37% and an area under the ROC curve (AUC) of 0.9724 for AD identification, and also an accuracy of 78.80% and an AUC of 0.8284 for mild cognitive impairment (MCI) identification. Moreover, the proposed method achieves an accuracy of 67.83% and an AUC of 0.6957 for separating between MCI converters and MCI non-converters (to AD). These performances demonstrate the superiority of the proposed method over the state-of-the-art classification methods.
AB - Previous studies have demonstrated that the use of integrated information from multi-modalities could significantly improve diagnosis of Alzheimer's Disease (AD). However, feature selection, which is one of the most important steps in classification, is typically performed separately for each modality, which ignores the potentially strong inter-modality relationship within each subject. Recent emergence of multi-task learning approach makes the joint feature selection from different modalities possible. However, joint feature selection may unfortunately overlook different yet complementary information conveyed by different modalities. We propose a novel multi-task feature selection method to preserve the complementary inter-modality information. Specifically, we treat feature selection from each modality as a separate task and further impose a constraint for preserving the inter-modality relationship, besides separately enforcing the sparseness of the selected features from each modality. After feature selection, a multi-kernel support vector machine (SVM) is further used to integrate the selected features from each modality for classification. Our method is evaluated using the baseline PET and MRI images of subjects obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Our method achieves a good performance, with an accuracy of 94.37% and an area under the ROC curve (AUC) of 0.9724 for AD identification, and also an accuracy of 78.80% and an AUC of 0.8284 for mild cognitive impairment (MCI) identification. Moreover, the proposed method achieves an accuracy of 67.83% and an AUC of 0.6957 for separating between MCI converters and MCI non-converters (to AD). These performances demonstrate the superiority of the proposed method over the state-of-the-art classification methods.
KW - Alzheimer's Disease
KW - Inter-modality relationship
KW - Mild cognitive impairment
KW - Multi-kernel support vector machine
KW - Multi-task feature selection
UR - http://www.scopus.com/inward/record.url?scp=84885160193&partnerID=8YFLogxK
U2 - 10.1016/j.neuroimage.2013.09.015
DO - 10.1016/j.neuroimage.2013.09.015
M3 - Article
C2 - 24045077
AN - SCOPUS:84885160193
SN - 1053-8119
VL - 84
SP - 466
EP - 475
JO - NeuroImage
JF - NeuroImage
ER -